Raj K. Puri, Chief Regulatory Officer at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 5,600 shares at $1.74 ($10K) on 2025-05-23, disclosed to the SEC on 2025-05-27.
Open-market purchase of $10k IOVA by Chief Regulatory Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.